Influence of Weight Loss on Cognitive Functions: A Pilot Study of a Multidisciplinary Intervention Program for Obesity Treatment.
Emma Adriana Chávez-ManzaneraMaura Ramírez-FloresMichelle DuranMariana TorresMariana RamírezMartha Kaufer-HorwitzSylvana StephanoLizette Quiroz-CasianCarlos Cantú-BritoErwin ChiquetePublished in: Brain sciences (2022)
There is a relationship between obesity and cognitive functioning. Our aim was to assess weight loss influence on global cognition and executive functioning (EF) in adults with obesity under a multidisciplinary weight loss program. In this six-month longitudinal study, we assessed 81 adults (age < 50 years) with body mass index (BMI) ≥ 30. EF and global cognitive performance were evaluated with the Montreal Cognitive Assessment (MoCA), Neuropsychological Battery of Executive Functions (BANFE-2) and Trail Making Test-Part B (TMT-B). Median age was 40.0 years (IQR: 31.5-47, 61% women), and the median BMI was 41.4 (IQR: 36.7-45.9). At a six-month follow-up, the mean weight loss was 2.67% (29.6% of patients achieved ≥5% weight loss). There was an improvement in EF evaluated with BANFE ( p = 0.0024) and global cognition with MoCA ( p = 0.0024). Women experienced more remarkable change, especially in EF. Weight loss did not correlate with cognitive performance, except for TMT-B (r-0.258, p = 0.026). In the regression analysis, only years of education predicted the MoCA score. This study showed that patients improved cognitive performance during the follow-up; nevertheless, the magnitude of weight loss did not correlate with cognitive improvement. Future studies are warranted to demonstrate if patients achieving ≥5% weight loss can improve cognition, secondary to weight loss.
Keyphrases
- weight loss
- bariatric surgery
- roux en y gastric bypass
- gastric bypass
- body mass index
- weight gain
- end stage renal disease
- ejection fraction
- newly diagnosed
- obese patients
- chronic kidney disease
- glycemic control
- quality improvement
- mild cognitive impairment
- randomized controlled trial
- prognostic factors
- type diabetes
- metabolic syndrome
- working memory
- pregnant women
- polycystic ovary syndrome
- patient reported
- skeletal muscle
- current status